90% of 50 and 59 years old are now fully vaccinated against Covid-19

The SCS vaccination teams have now inoculated 2,425,132 vaccines since the beginning of the campaign and up until yesterday, 1,107,570 people had been fully immunized which represents 56.49% of the target population over 12 years of age in the Canary Islands.

There are now 1,434,045 people In the Archipelago who have received at least one dose of the vaccine, which is 73.14% of the target population, which has been increased by including the population over 12 years of age in the National Vaccination Strategy.

This means that 215,178 extra people included in the age group of 12 to 15 years have been added to the statistic, so that now the target population of the Canary Islands amounts to 1,960,774 people. Taking the population over 16 years of age as reference, 76.64% have been vaccinated.

Group coverage so far:
In the latest revision of the National Vaccination Strategy, the following vaccination and prioritization groups are established:

Stage I:

Group 1: COMPLETE

Group 2: COMPLETE

Group 3: 100% one dose and 99.95% two doses. Non front-line health and social health personnel:

Group 4: 100% one dose and 99.53% two doses. Large household dependents.

Stage II:

Group 5: 100% one dose and 97.48% two doses. People aged over 60.
Group 5A: People aged 80 and over
Group 5B: People from 70 to 79 years old
Group 5C: People from 66 to 69 years old

Group 6: 98.87% one dose and 97.86% two doses. Groups with an essential function for society: police, army, emergency services, teachers.

Group 7: 100% one dose and 96.36% two doses. People under 60 years of age with severe Covid-19 high-risk conditions, ie health complications.

Group 8: 80.38% one dose and 53.37% two doses. People aged 60-65 years old.

Group 9: 91.22% one dose and 91.18% two doses. People aged 50-59 years old.

Group 10: 62.27% with full schedule. People aged 40-49 years old.

Stage III:

Group 11: 51.49% with one dose and 27.30% with two doses. People between 30 and 39 years old.

Group 12: 43.00% with one dose. People between 20 and 29 years old.

Group 13: 15.03% with one dose. People between 12 and 19 years old.